Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
About this episode
Drs. Antoine Lanot and Gil Yosipovitch discuss the management of CKD-associated pruritus and the role of antihistamines in treatment.
Faculty: Antoine Lanot, MD, PhD Faculty: Gil Yosipovitch, MD Despite effective and recommended therapies, many healthcare providers still consider antihistamines as the first-choice treatment for CKD-associated pruritus. Join Drs. Antoine Lanot and Gil Yosipovitch as they review a clinical patient case from a multidisciplinary perspective and consider best practices for the diagnosis, treatment, and management of CKD-aP.
People in this episode
Guests: Antoine Lanot, MD, PhD, Gil Yosipovitch, MD
Mentioned in this episode
Organizations: CME, ReachMD
More episodes of CME
- Counseling Patients on Their Future with Biologics
- Safety in oHCM Therapy: How and When to Transition Treatment?
- Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
- Transforming Care in Pediatric Patients With C3 Glomerulopathy: Targeting C3 at the Source
- Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
- The Future of HNSCC: Aligning Teams, Transforming Care
Explore listener stats, chart rankings, contacts and more on the CME podcast page.